Please login to the form below

Not currently logged in
Email:
Password:

Celgene appoints UK inflammation and immunology director

Rob Moore joins from Abbott
celgene Rob-Moore

Celgene has appointed Rob Moore to head its inflammation and immunology business in the UK and Ireland.

Moore joins from AbbVie (formerly Abbott) where he was rhemautology senior business unit manager for the UK.

During his time at Abbott/AbbVie Moore worked across Western Europe and Canada, including two years in Paris as immunology commercial director, dermatology.

He also set up and led the UK sales team in gastroenterology before moving on to create the business unit for dermatology in 2009, wherein he led the launch of the huge-selling anti-inflammatory drug Humira (adalimumab).

Sam Pearce, VP and general manager, Celgene UK and Ireland, said: “We have an opportunity here to offer effective solutions to patients in need, and are confident that Rob has the knowledge and experience to help us deliver these. “

14th March 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics